Document Type
Report
Publication Date
2-24-2020
Abstract
This research report describes results from an implementation science study that explored the feasibility and acceptability of administering depot medroxyprogesterone acetate-subcutaneous (DMPA-SC) among health-care providers and family planning (FP) clients in Ghana. DMPA-SC is an injectable contraceptive method that can be self-administered. The study, conducted by the Population Council through the USAID-funded Evidence Project in collaboration with the Ghana Health Service, was implemented in rural, peri-urban, and urban areas of the Ashanti and Volta regions. A total of 150 health-care providers were trained to administer DMPA-SC and to train clients on self-injection. Clients assessed as being competent self-injected under the provider’s supervision and could take two DMPA-SC doses home for future self-injections. Results indicate that DMPA-SC self-injection is feasible and acceptable to both providers and FP clients. The report also examines the socio-demographic profile of providers and clients, method continuation, and feasibility and acceptability of home self-injection. Results have informed the national scale-up of DMPA-SC in public and private facilities, which began in April 2019.
Recommended Citation
Nai, Dela, Patrick Aboagye, Kamil Fuseini, Elizabeth Tobey, Aparna Jain, Nora Maresh, and Rebecca Fertziger. 2020. "Introduction of DMPA-SC self-injection in Ghana: A feasibility and acceptability study using Sayana® Press," Research report. Washington, DC: Population Council, The Evidence Project.
DOI
10.31899/rh11.1050
Language
English
Project
The Evidence Project
Included in
Demography, Population, and Ecology Commons, Family, Life Course, and Society Commons, Gender and Sexuality Commons, International Public Health Commons, Medicine and Health Commons